Activating alleles of JAK3 in acute megakaryoblastic leukemia-Reference-Cited by-同舟云学术

Activating alleles of JAK3 in acute megakaryoblastic leukemia

Published:2006-07 Issue:1 Volume:10 Page:65-75
ISSN:1535-6108
Container-title:Cancer Cell
language:en
Short-container-title:Cancer Cell

Author:

Walters Denise K.,Mercher Thomas,Gu Ting-Lei,O'Hare Thomas,Tyner Jeffrey W.,Loriaux Marc,Goss Valerie L.,Lee Kimberly A.,Eide Christopher A.,Wong Matthew J.,Stoffregen Eric P.,McGreevey Laura,Nardone Julie,Moore Sandra A.,Crispino John,Boggon Titus J.,Heinrich Michael C.,Deininger Michael W.,Polakiewicz Roberto D.,Gilliland D. Gary,Druker Brian J.

Publisher

Elsevier BV

Subject

Cancer Research,Cell Biology,Oncology

Reference66 articles.

1. A novel mode of Gleevec binding is revealed by the structure of spleen tyrosine kinase;Atwell;J. Biol. Chem.,2004

2. Acquired mutation of the tyrosine kinase JAK2 in human myeloproliferative disorders;Baxter;Lancet,2005

3. Regulation of constitutive STAT5 phosphorylation in acute myeloid leukemia blasts;Birkenkamp;Leukemia,2001

4. Crystal structure of the Jak3 kinase domain in complex with a staurosporine analog;Boggon;Blood,2005

5. JAK3 inhibition, a viable new modality of immunosuppression for solid organ transplants;Borie;Trends Mol. Med.,2004

Cited by 270 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Therapeutic advances of targeting receptor tyrosine kinases in cancer;Signal Transduction and Targeted Therapy;2024-08-14

2. A clinically compatible in vitro drug-screening platform identifies therapeutic vulnerabilities in primary cultures of brain metastases;Journal of Neuro-Oncology;2024-07-10

3. Janus Kinase 3 (JAK3): A Critical Conserved Node in Immunity Disrupted in Immune Cell Cancer and Immunodeficiency;International Journal of Molecular Sciences;2024-03-04

4. JAK/STAT in leukemia: a clinical update;Molecular Cancer;2024-01-26

5. Single-cell RNA-seq analyses inform necroptosis-associated myeloid lineages influence the immune landscape of pancreas cancer;Frontiers in Immunology;2023-12-12